ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
풀베스트란트 주사제 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 시장 성장은 복합 치료의 중시가 고조되고, 신규 적응증의 임상시험에 대한 투자가 증가하는 점 등에 기인할 것으로 예상됩니다.
유방암의 유병률 증가는 향후 몇 년 동안 풀베스트란트 주사제 시장의 성장을 가속할 것으로 예측됩니다. 이러한 유병률 증가는 인구의 고령화가 주된 원인입니다. 풀베스트란트 주사제는 호르몬 수용체 양성 유방암의 치료에 중요한 역할을 하고, 진행형 또는 치료 저항성의 유방암 환자에게 유효한 선택지를 제공해 전체적인 치료 결과를 향상시킵니다. 2025년 3월, 미국의 비영리단체 Breastcancer.org의 보고서에 따르면 신규 암 판정 중 유방암은 약 32%를 차지하였으며 2025년까지 침윤성 유방암으로 진단되는 여성은 31만 6,950명, 비침윤성 유방암으로 진단되는 여성은 5만 9,080명으로 추정됩니다. 그 결과, 유방암 이환율 증가가 풀베스트란트 주사제 시장의 확대에 크게 기여하고 있습니다.
풀베스트란트 주사제 시장의 주요 기업은 제품 포트폴리오의 확충과 시장에서의 존재감 강화를 위해 규제 당국의 승인 취득을 우선시하고 있습니다. 2022년 12월, Alembic Pharmaceuticals는 호르몬 수용체 양성 유방암의 치료를 위한 제네릭 의약품 풀베스트란트 주사제(250mg/5mL)에 대해 미국 식품의약국(USFDA)으로부터 약식 신약 신청(ANDA) 승인을 취득했습니다. 풀베스트란트는 근육내 주사로 투여되며, 보통 의료 종사자가 일정 스케줄에 맞춰 투여합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 팬데믹과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 풀베스트란트 주사제 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계 풀베스트란트 주사제 시장 : 성장률 분석
세계의 풀베스트란트 주사제 시장 실적 : 규모와 성장(2019-2024년)
세계의 풀베스트란트 주사제 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 풀베스트란트 주사제 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 풀베스트란트 주사제 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
선발 의약품
제네릭 의약품
세계의 풀베스트란트 주사제 시장 : 투여량별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
싱글 도즈 바이알
멀티 도즈 바이알
프리필드 주사기
세계의 풀베스트란트 주사제 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
근육내 주사
피하 주사
정맥 주사
세계의 풀베스트란트 주사제 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
유방암 치료
호르몬 수용체 양성 전이성 유방암
기타 용도
세계의 풀베스트란트 주사제 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원 약국
소매 약국
온라인 약국
세계의 풀베스트란트 주사제 시장, 선발 의약품 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 풀베스트란트 주사제 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 풀베스트란트 주사제 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
풀베스트란트 주사제 시장 : 경쟁 구도
풀베스트란트 주사제 시장 : 기업 프로파일
AstraZeneca plc : 개요, 제품 및 서비스, 전략 및 재무 분석
Fresenius Kabi AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Intas Pharmaceuticals Limited : 개요, 제품 및 서비스, 전략 및 재무 분석
Sandoz Group AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Apotex Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Dr. Reddy's Laboratories
Cadila Pharmaceuticals Ltd.
Amneal Pharmaceuticals Inc.
Biocon Ltd.
Glenmark Pharmaceuticals Ltd.
Alkem Laboratories Ltd.
Alembic Pharmaceuticals
Eskayef Pharmaceuticals Ltd.
Natco Pharma Ltd.
Celon Laboratories Ltd.
Therdose Pharma
Eugia Pharma
Formative Pharma
Halsted Pharma
Metta Life Sciences
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
풀베스트란트 주사제 시장(2029년) : 새로운 기회를 제공하는 국가
풀베스트란트 주사제 시장(2029년) : 새로운 기회를 제공하는 부문
풀베스트란트 주사제 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
CSM
영문 목차
영문목차
Fulvestrant injection is a synthetic estrogen receptor antagonist used to treat hormone receptor-positive breast cancer in postmenopausal women. It functions by blocking and degrading estrogen receptors, thereby inhibiting the growth of cancer cells that depend on estrogen. This mechanism helps to slow or stop tumor progression, ultimately improving patient outcomes.
Fulvestrant injections are classified into original drugs and generic drugs. Original drugs refer to the first formulations developed and introduced by pharmaceutical companies. These injections come in various dosage forms, such as single-dose vials, multi-dose vials, and pre-filled syringes, and are administered via intramuscular, subcutaneous, or intravenous routes. They are used for treating breast cancer, hormone receptor-positive metastatic breast cancer, and other related conditions. Distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies.
The fulvestrant injection market research report is one of a series of new reports from The Business Research Company that provides fulvestrant injection market statistics, including fulvestrant injection industry global market size, regional shares, competitors with a fulvestrant injection market share, detailed fulvestrant injection market segments, market trends and opportunities, and any further data you may need to thrive in the fulvestrant injection industry. This fulvestrant injection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The fulvestrant injection market size has grown strongly in recent years. It will grow from $1.24 billion in 2024 to $1.34 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth during the historic period can be credited to the rising incidence of breast cancer, greater awareness of hormone receptor-positive breast cancer, the presence of branded fulvestrant products, expansion of oncology treatment infrastructure, and supportive reimbursement policies in developed nations.
The fulvestrant injection market size is expected to see strong growth in the next few years. It will grow to $1.83 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to a shift toward combination therapies, increased accessibility due to the introduction of biosimilars, expansion in emerging markets, a rising emphasis on personalized cancer treatment, and increased investment in clinical trials for new indications. Key trends expected during this period include advancements in fulvestrant injection, the development of combination therapies, investigation into subcutaneous delivery methods, and the integration of personalized medicine approaches through biomarker targeting.
The rising prevalence of breast cancer is anticipated to drive the growth of the fulvestrant injection market in the coming years. Breast cancer is characterized by the uncontrolled proliferation of abnormal cells in breast tissue, leading to the formation of malignant tumors that may invade nearby tissues or metastasize to other parts of the body. This increasing prevalence is largely due to aging populations, as the risk of developing breast cancer rises with age because of prolonged estrogen exposure and the gradual buildup of genetic mutations. Fulvestrant injection plays a crucial role in treating hormone receptor-positive breast cancer by blocking estrogen's effect on tumor growth, offering an effective option for patients with advanced or treatment-resistant forms of the disease and improving overall treatment outcomes. For example, in March 2025, Breastcancer.org, a U.S.-based nonprofit organization, reported that breast cancer represents approximately 32% of all new cancer diagnoses, with an estimated 316,950 women projected to be diagnosed with invasive breast cancer and 59,080 with non-invasive types by 2025. As a result, the growing incidence of breast cancer is contributing significantly to the expansion of the fulvestrant injection market.
Leading companies in the fulvestrant injection market are prioritizing the acquisition of regulatory approvals to broaden their product portfolios and strengthen their market presence. Regulatory approvals are official authorizations granted by government agencies, confirming that a product complies with established standards for safety, efficacy, and quality. For example, in December 2022, Alembic Pharmaceuticals, an India-based pharmaceutical firm, received an Abbreviated New Drug Application (ANDA) approval from the U.S. Food & Drug Administration (USFDA) for its generic Fulvestrant injection (250 mg/5 mL), indicated for the treatment of hormone receptor-positive breast cancer. Fulvestrant is delivered via intramuscular injection, typically administered by a healthcare provider following a prescribed schedule. It functions by binding to and degrading estrogen receptors, thereby preventing estrogen from promoting the growth of hormone receptor-positive breast cancer cells.
In November 2024, Incyclix Bio LLC, a U.S.-based clinical-stage biopharmaceutical company, entered into a partnership with Eli Lilly and Company to advance the development of breast cancer treatments. The collaboration is focused on assessing whether the addition of the CDK2 inhibitor INX-315 to the existing combination of Verzenio (abemaciclib) and fulvestrant can enhance clinical outcomes in patients with HR+/HER2- metastatic breast cancer who have experienced disease progression following prior CDK4/6 inhibitor therapy. Eli Lilly and Company is a pharmaceutical company based in the United States.
Major players in the fulvestrant injection market are AstraZeneca plc, Fresenius Kabi AG, Intas Pharmaceuticals Limited, Sandoz Group AG, Apotex Inc., Dr. Reddy's Laboratories, Cadila Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Biocon Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Alembic Pharmaceuticals, Eskayef Pharmaceuticals Ltd., Natco Pharma Ltd., Celon Laboratories Ltd., Therdose Pharma, Eugia Pharma, Formative Pharma, Halsted Pharma, and Metta Life Sciences.
North America was the largest region in the fulvestrant injection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in fulvestrant injection report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the fulvestrant injection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The fulvestrant injection market consists of sales of ready-to-use formulations and depot injections. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Fulvestrant Injection Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on fulvestrant injection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for fulvestrant injection ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fulvestrant injection market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Original Drugs; Generic Drugs
2) By Dosage Formulation: Single-Dose Vials; Multi-Dose Vials; Pre-Filled Syringes
3) By Administration Route: Intramuscular Injection; Subcutaneous Injection; Intravenous Injection
4) By Application: Breast Cancer Treatment; Hormone Receptor-Positive Metastatic Breast Cancer; Other Applications
5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Original Drugs: Branded Formulations; Patented Molecules; Hospital-Procured Brands; Oncologist-Prescribed Brands; High-Cost Segment
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Fulvestrant Injection Market Characteristics
3. Fulvestrant Injection Market Trends And Strategies
4. Fulvestrant Injection Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Fulvestrant Injection Growth Analysis And Strategic Analysis Framework
5.1. Global Fulvestrant Injection PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Fulvestrant Injection Market Growth Rate Analysis
5.4. Global Fulvestrant Injection Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Fulvestrant Injection Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Fulvestrant Injection Total Addressable Market (TAM)
6. Fulvestrant Injection Market Segmentation
6.1. Global Fulvestrant Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Original Drugs
Generic Drugs
6.2. Global Fulvestrant Injection Market, Segmentation By Dosage Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single-Dose Vials
Multi-Dose Vials
Pre-Filled Syringes
6.3. Global Fulvestrant Injection Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intramuscular Injection
Subcutaneous Injection
Intravenous Injection
6.4. Global Fulvestrant Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Breast Cancer Treatment
Hormone Receptor-Positive Metastatic Breast Cancer
Other Applications
6.5. Global Fulvestrant Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.6. Global Fulvestrant Injection Market, Sub-Segmentation Of Original Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Branded Formulations
Patented Molecules
Hospital-Procured Brands
Oncologist-Prescribed Brands
High-Cost Segment
6.7. Global Fulvestrant Injection Market, Sub-Segmentation Of Generic Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Branded Generics
Non-Branded Generics
Biosimilar Generics
Low-Cost Institutional Generics
Tender-Based Supply Generics
7. Fulvestrant Injection Market Regional And Country Analysis
7.1. Global Fulvestrant Injection Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Fulvestrant Injection Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Fulvestrant Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Fulvestrant Injection Market, Segmentation By Dosage Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Fulvestrant Injection Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Fulvestrant Injection Market
9.1. China Fulvestrant Injection Market Overview
9.2. China Fulvestrant Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Fulvestrant Injection Market, Segmentation By Dosage Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Fulvestrant Injection Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Fulvestrant Injection Market
10.1. India Fulvestrant Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Fulvestrant Injection Market, Segmentation By Dosage Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Fulvestrant Injection Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Fulvestrant Injection Market
11.1. Japan Fulvestrant Injection Market Overview
11.2. Japan Fulvestrant Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Fulvestrant Injection Market, Segmentation By Dosage Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Fulvestrant Injection Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Fulvestrant Injection Market
12.1. Australia Fulvestrant Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Fulvestrant Injection Market, Segmentation By Dosage Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Fulvestrant Injection Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Fulvestrant Injection Market
13.1. Indonesia Fulvestrant Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Fulvestrant Injection Market, Segmentation By Dosage Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Fulvestrant Injection Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Fulvestrant Injection Market
14.1. South Korea Fulvestrant Injection Market Overview
14.2. South Korea Fulvestrant Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Fulvestrant Injection Market, Segmentation By Dosage Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Fulvestrant Injection Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Fulvestrant Injection Market
15.1. Western Europe Fulvestrant Injection Market Overview
15.2. Western Europe Fulvestrant Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Fulvestrant Injection Market, Segmentation By Dosage Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Fulvestrant Injection Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Fulvestrant Injection Market
16.1. UK Fulvestrant Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Fulvestrant Injection Market, Segmentation By Dosage Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Fulvestrant Injection Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Fulvestrant Injection Market
17.1. Germany Fulvestrant Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Fulvestrant Injection Market, Segmentation By Dosage Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Fulvestrant Injection Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Fulvestrant Injection Market
18.1. France Fulvestrant Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Fulvestrant Injection Market, Segmentation By Dosage Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Fulvestrant Injection Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Fulvestrant Injection Market
19.1. Italy Fulvestrant Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Fulvestrant Injection Market, Segmentation By Dosage Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Fulvestrant Injection Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Fulvestrant Injection Market
20.1. Spain Fulvestrant Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Fulvestrant Injection Market, Segmentation By Dosage Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Fulvestrant Injection Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Fulvestrant Injection Market
21.1. Eastern Europe Fulvestrant Injection Market Overview
21.2. Eastern Europe Fulvestrant Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Fulvestrant Injection Market, Segmentation By Dosage Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Fulvestrant Injection Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Fulvestrant Injection Market
22.1. Russia Fulvestrant Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Fulvestrant Injection Market, Segmentation By Dosage Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Fulvestrant Injection Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Fulvestrant Injection Market
23.1. North America Fulvestrant Injection Market Overview
23.2. North America Fulvestrant Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Fulvestrant Injection Market, Segmentation By Dosage Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Fulvestrant Injection Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Fulvestrant Injection Market
24.1. USA Fulvestrant Injection Market Overview
24.2. USA Fulvestrant Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Fulvestrant Injection Market, Segmentation By Dosage Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Fulvestrant Injection Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
